Pathogenic variants and germline mutations in BRCA1 and BRCA2 can increase the risk of developing breast cancer at a younger age, as these mutations represent more than 50% of all mutations in breast cancer-related genes in young women of specific populations (Chelmow et al., 2020). This evidence concerns the gene BRCA2 and breast cancer.